WASHINGTON, Mar 23: The US Supreme Court will hear arguments on Monday over whether big drug companies can settle patent litigation with generic rivals by making deals to keep cheaper products off the market. US and state regulators say the practice costs consumers, insurers and government billions of dollars annually. (agencies)
Follow our WhatsApp channel